Biocon Limited (BOM:532523)
366.00
+3.65 (1.01%)
At close: Nov 20, 2026
Biocon Market Cap
Biocon has a market cap or net worth of 593.35 billion as of November 20, 2026. Its market cap has increased by 8.42% in one year.
Market Cap
593.35B
Enterprise Value
746.59B
Revenue
174.15B
Global Rank
n/a
Country Rank
n/a
PE Ratio
124.50
ChartMarket Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 593.35B, an increase of 1,206.56%. That is a compound annual growth rate of 12.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 593.35B | 12.88% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 593.35B |
| Anthem Biosciences | 534.47B |
| OneSource Specialty Pharma | 184.62B |
| Concord Biotech | 114.76B |
| Blue Jet Healthcare | 97.24B |
| Supriya Lifescience | 50.06B |
| Zota Health Care | 44.82B |
| Panacea Biotec | 20.64B |